张学农

154e983c-b76a-4adb-afec-c2b184f3f0a7.jpg
 

张学农,男,1962年出生,博士,教授、博士生导师,苏州大学药学院副院长。2003.8~ 作为学科带头人引进苏州大学药学院;现为国家发改委价格评审中心专家成员、国家药审中心新药审评专家库成员,国家执业药师工作专家库首批入选专家、中国药学会药剂学分会委员,江苏省药学会药剂学会副主任委员。国家教育部、国家自然基金评审专家、江苏省人事厅、科技厅和教育厅评审专家。《抗感染药学》副主编,《中国药物警戒》常务编委,《中国药学杂志》和《苏州大学学报(医学版)编委。《Nanomedicine》、《Curr Med Chem》、Current Nanoscience》和《J Chromatogr B》等期刊审稿人江苏省“333高层次人才培养工程”中青年科学技术带头人和江苏省“六大高峰人才”。 主持国家自然科学基金、国家科技部科技型中小企业技术创新基金、国家科技支撑计划和江苏省社会发展项目等。申请发明专利10余项,授权3项。指导学生论文中,2篇江苏省优秀硕士论文,3篇获苏州大学优秀硕士论文,2篇获江苏省高校本科论文三等奖。获江苏省中医药科技进步二等奖1项,苏州市科学技术进步奖三等奖2项。苏州大学周氏科研奖1次,陈金荣生命科学奖3次。
联系地址:
苏州大学医学部药学院 药剂学教研室,
苏州市工业园区仁爱路199号邮编:215123
联系电话&传真:0512-65882087
E-mailzhangxuenong@163.com
zhangxuenong@suda.edu.cn,
主要研究方向:
1、靶向递药系统的研究
2、缓控释新材料与新技术
 
发表论文: 
在国内外(医)药学期刊上发表论文100多篇。其中在药物制剂及生物医学材料等领域的权威期刊包括,《Biomaterials》、《Nanomedicine》、《J Pharm Exp Ther》、《Expert Opinion on Drug Delivery》、《Int J Nanomedicine》、《Current Nanoscience》、《J Chromatogr B》和J Biomed Mater Res》发表论文50余篇。近年来代表论文:
1.      Zhu QL,Zhou Y, Guan M, Zhou XF, Yang SD,Liu Y, Chen WL, Zhang CG,Yuan ZQ, Liu C, Zhu AJ,Zhang XN*.Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy.Biomaterials, 2014 (in press,一区,IF 7.604, )
2.      BeiYY,Yuan ZQ, ZhangL,Zhou XF, Chen WL, Xia P, Liu Y, You BG, Hu XJ, Zhu QL, Zhang CG, Zhang XN*, Yong J.Manuscript Title: Novel Self-assembled Micelles based on Palmitoyl-trimethyl-chitosan for Efficient Delivery of Harmine to Liver Cancer. Expert Opinion on Drug Delivery, 2014 (in press,二区,IF 4.85)
3.      Zhang CG,Zhu QL,Zhou Y, Liu Y, Chen WL, Yuan ZQ, Yang SD, Zhou XF, Zhu AJ, Zhang XN*, Jin Y.N-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein (LDL) for targeted loaded-osthole delivery to -(LDLr)-rich tumors International Journal of Nanomedicine,2014 (in press,二区, IF 3.43)
4.      Liu Y, Wang XQ, Ren WX, Chen YL, Yu Y, Zhang JK, Bawudong D, Gu JP, Xu XD, Zhang XN*. Novel albendazole-chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats. J Biomed Mater Res B Appl Biomater. 2013 101B(6): 998-1005. doi: 10.1002/jbm.b.32908.二区,IF 2.31
5.      Zhang GY, Zhou XF, Zhou XY, Wen QY, You BG, Liu Y, Zhang XN*, Jin Y.Effect of alginate-chitosan sustained release microcapsules for transhepatic arterial embolization in VX2 rabbit liver cancer model. J Biomed Mater Res A. 2013 ,101(11):3192-3200. 二区,IF 2.83
6.      Bei YY, Zhou XF, You BG, Yuan ZQ, Chen WL, Xia P, Liu Y, Jin Y, Hu XJ, Zhu QL, Zhang CG, Zhang XN*, Zhang L. Application of the central composite design to optimize the preparation of novel micelles of harmine. International Journal of Nanomedicine. 2013, 8:1795-1808二区,IF 3.43
7.          Hu XJ, Liu Y, Zhou XF, Zhu QL, Bei YY, You BG, Zhang CG, Chen WL, Wang ZL, Zhang XN, FanYJ.Synthesis and characterization of low-toxicity N-caprinoyl-N-trimethyl chitosan as cancer-targeting self-assembled micelles for osthole . International Journal of Nanomedicine. 2013, 8:3543-3558二区,IF 3.43
8.      Ding,XY Hong CJ, ZhouXF, Sun JT, LiuY , Gu ZL ,Zhu AJ, Chen WL, Shi LS,Zhang XN.The mechanism of polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticles .Current Nanoscience, 2013, 9, 401-406  三区,IF 1.87
9.      Guan M, Zhou Y, Zhu QL, Liu Y, Bei YY,Zhang XN*,Zhang Q. N-Trimethyl Chitosan Nanoparticle–encapsulated Lactosyl-Norcantharidin for Liver Cancer Therapy with High Targeting Efficacy. Nanomedicine: Nanotechnology, Biology, and Medicine. 2012,8:1172-1181(IF 6.93,一区)
10. Zhu QL, Zhou Y, Guan M, Yu DJ, Zhou XF, Liu Y, Xu JY, Wu Y, Gu ZL, Xing KL, Zhu AJ, Chen WL, Shi LS, Zhang XN, Zhang Q.Hepatocyte-targeted delivery using pH-sensitive liposomes loaded with lactosyl-norcantharitin phospholipid complex: preparation, characterization, and therapeutic evaluation in vivo and in vitro. Curr Med Chem. 2012, 19(33):5754-5763 二区 4.07
11. Ding XY, Hong CJ, Liu Y, Gu ZL, Xing KL, Zhu AJ, Chen WL, Shi LS, Zhang XN*Zhang Q Pharmacokinetics, tissue distribution, and metabolites of polyvinylpyrrolidone coated norcantharidin chitosan nanoparticle formulation in rats and mice by LC-MS/MS. International Journal of Nanomedicine ,2012:7 1723-1735 IF 4.93二区
12. BeiYY,Chen XY, Liu Y1, Xu JY, Wang WJ, Gu ZL,Xing KL, Zhu AJ, Chen WL, Shi LS, Zhang XN*Zhang Q. Novel norcantharidin- loaded liver targeting chitosan nanoparticles to enhance intestinal absorption.International Journal of Nanomedicine ,2012:7 1819-1827, IF 3.43二区
13. Guan M, Zhu QL, Liu Y, Bei YY, Gu ZL, Zhang XN*,Zhang Q.Uptake and Transport of a Novel Anticancer Drug Delivery System Lactosyl-norcantharidin-associated N-trimethyl Chitosan Nanoparticles across Intestinal Caco-2 Cell Monolayers.International Journal of Nanomedicine ,2012:7 1921-1930,IF 3.43二区
14. Wang Q,Zhang L, Hu W, Hu ZH, Bei YY, Xu JY, Wang WJ, Zhang XN*, Zhang Q. Norcantharidin-associated galactosylated chitosan nanoparticles for dual hepatocyte-targeted delivery. Nanomedicine: Nanotechnology, Biology, and Medicine . 2010,6(2): 371–381.(IF 6.93,一区)
15. Fang ZG, YouBG Chen YG, Zhang JK, Liu YQ, Zhang XN*, Zhang Q.Analysis of cyclosporine A and its metabolites in rat urine and feces by liquid chromatography-tandem mass spectrometry. J Chromatography B,2010,878:1153-1162,三区, IF=2.94.